Table 3: Group comparison of disorder classification and ambulatory treatment by mortality.
|
Total |
Did Not Survive |
Survived |
P-value |
Started of symptoms until register |
7.6 ± 6.6 |
7.25 ± 5.47 |
7.95 ± 7.24 |
< 0.001 |
Classification disorder |
< 0.001 |
|||
Influeza type disease |
3495 (47.3) |
649 (22.2) |
2846 (63.6) |
|
Serious Acute Respiratory Infection |
3899 (52.7) |
2268 (77.8) |
1631 (36.4) |
|
Ambulatory treatment |
||||
Antipiretics |
3292 (44.5) |
1142 (39.7) |
2150 (48.3) |
< 0.001 |
Antibiotics |
1746 (23.6) |
739 (68.0) |
1007 (31.2) |
< 0.001 |
Antiviral |
1098 (14.8) |
586 (21.7) |
512 (11.9) |
< 0.001 |
Type of antiviral |
|
|
|
0.004 |
Aciclovir |
2 (0.02) |
0 |
2 (0.2) |
|
Amantadina |
18 (0.2) |
5 (0.9) |
13 (2.6) |
|
Lopinavir/Ritonavir |
28 (0.4) |
7 (1.2) |
21 (4.1) |
|
Oseltamivir |
1038 (14.0) |
570 (97.4) |
468 (92.3) |
|
Rimantadina |
4 (0.1) |
2 (0.3) |
2 (0.4) |
|
Zavamivir |
2 (0.02) |
1 (0.2) |
1 (0.2) |